Key points are not available for this paper at this time.
Non-alcoholic fatty liver disease (NAFLD) is a serious threat to human health, and the investigation for non-invasive biomarkers to quantify hepatic fat content appears to be crucial. In the study, PDFF was used to quantify liver fat content, assess the grade and degree of hepatic steatosis. PDFF was found to be effective in assessing fat content in NAFLD, which is expected to be used as a biomarker to assess the grading of steatosis in patients with NAFLD.
Qi et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: